DOI: 10.12809/hkmj154509
© Hong Kong Academy of Medicine. CC BY-NC-ND 4.0
LETTER TO THE EDITOR
Reversal of warfarin in life-threatening bleeding
Daniel SK Ng, FACEM, FHKAM (Emergency Medicine)
Emergency Department, Swan District Hospital, 1 Eveline Road, Middle Swan, Western Australia 6056
Corresponding author: Dr Daniel SK Ng (daniel.ng@health.wa.gov.au)
Full
paper in PDF
To the Editor—I read with interest the article “The
benefit of prothrombin complex concentrate in
decreasing neurological deterioration in patients
with warfarin-associated intracerebral haemorrhage”
by Fong et al in the December 2014 issue of the Hong
Kong Medical Journal.1 The Australian guidelines
for warfarin reversal quoted in the article were
outdated.2 The most recent Australian guidelines
can be found in the March 2013 issue of the Medical
Journal of Australia.3
References
1. Fong WC, Lo WT, Ng YW, et al. The benefit of prothrombin complex concentrate in decreasing neurological deterioration in patients with warfarin-associated intracerebral haemorrhage. Hong Kong Med J 2014;20:486-94. Crossref
2. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem
HH, Wood EM; Warfarin Reversal Consensus Group. Warfarin reversal: consensus guidelines, on behalf of the
Australasian Society of Thrombosis and Haemostasis. Med J Aust 2004;181:492-7.
3. Tran HA, Chunilal SD, Harper PL, Tran H, Wood EM, Gallus AS; Australasian Society of Thrombosis and Haemostasis (ASTH). An update of consensus guidelines for warfarin reversal. Med J Aust 2013;198:198-9. Crossref